English | Español
Jamie Barrand | Dec 24, 2015

AHA names two injectable PCSK9 inhibitors among 2015's top research advances
Jamie Barrand | Dec 24, 2015

Merck, Pfizer launch phase III trial of ovarian cancer therapy
Jamie Barrand | Dec 24, 2015

New study links GABA activity to severity of autism symptoms
Jamie Barrand | Dec 24, 2015

AstraZeneca releases preliminary results from lung cancer drug's clinical trial
Jamie Barrand | Dec 24, 2015

FTA funds National Aging and Disability Transportation Center, improves accessibility
Jamie Barrand | Dec 24, 2015

The AIDS Institute officials laud rejection of HIV funding cuts
Jamie Barrand | Dec 24, 2015

CPR study named one of AHA's top research advances of 2015
Jamie Barrand | Dec 24, 2015

FDA approves Zurampic for treatment of gout

Trending
Patient Daily | Sep 3, 2025

Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+ Pharmaceuticals
Patient Daily | Sep 4, 2025

PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+ Pharmaceuticals
Patient Daily | Sep 2, 2025

Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’
+ Pharmaceuticals
Patient Daily | Aug 29, 2025

Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’